Cherry Lai is a finance professional with significant experience in the pathology and auditing sectors. At Healius Limited, Cherry served as Finance Business Partner for Laverty Pathology from February 2020 to January 2023, focusing on cost and revenue analysis, budgeting, and strategic finance initiatives. Previous roles at Healius include Commercial Finance Analyst and Revenue Systems Manager, emphasizing business insights and financial reporting. Before joining Healius, Cherry worked at KPMG as a Senior Auditor and Accountant, contributing to national audit processes, and held a position as Assistant Manager for Sydney Enterprise. Cherry's early career included experience as an Auditor at Moore Stephens. Educational qualifications comprise a Graduate Diploma in Accounting and Chartered Accountant certification from Chartered Accountants Australia and New Zealand, alongside a Bachelor of Commerce from the University of New South Wales.
This person is not in the org chart
This person is not in any teams
This person is not in any offices